Huiwen Jiang

1.1k total citations
27 papers, 533 citations indexed

About

Huiwen Jiang is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Huiwen Jiang has authored 27 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Huiwen Jiang's work include CAR-T cell therapy research (14 papers), Virus-based gene therapy research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Huiwen Jiang is often cited by papers focused on CAR-T cell therapy research (14 papers), Virus-based gene therapy research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Huiwen Jiang collaborates with scholars based in China, United Kingdom and Macao. Huiwen Jiang's co-authors include Heng Mei, Yu Hu, Lu Tang, Lin Liu, Yaohui Wu, Lisha Ai, Jun Deng, Tao Guo, Chenggong Li and Mengyi Du and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Huiwen Jiang

24 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiwen Jiang China 11 367 142 135 122 105 27 533
Chunrong Tong China 11 337 0.9× 113 0.8× 108 0.8× 104 0.9× 86 0.8× 50 450
Aimee C. Talleur United States 13 399 1.1× 199 1.4× 117 0.9× 105 0.9× 100 1.0× 47 583
Carrie Yuen United States 7 284 0.8× 123 0.9× 163 1.2× 77 0.6× 102 1.0× 19 470
Ruihao Huang China 10 356 1.0× 199 1.4× 171 1.3× 88 0.7× 104 1.0× 29 546
Katherine D. Cummins United States 8 408 1.1× 123 0.9× 281 2.1× 175 1.4× 147 1.4× 18 595
Elise McCormack United States 4 351 1.0× 137 1.0× 118 0.9× 91 0.7× 104 1.0× 8 565
Nobuhiko Imahashi Japan 14 306 0.8× 283 2.0× 111 0.8× 183 1.5× 91 0.9× 41 622
Jiazhen Cui China 11 312 0.9× 118 0.8× 139 1.0× 74 0.6× 76 0.7× 39 423
Evandro D. Bezerra United States 9 393 1.1× 56 0.4× 80 0.6× 117 1.0× 95 0.9× 31 523
Kotaro Miyao Japan 11 215 0.6× 90 0.6× 91 0.7× 83 0.7× 73 0.7× 34 377

Countries citing papers authored by Huiwen Jiang

Since Specialization
Citations

This map shows the geographic impact of Huiwen Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiwen Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiwen Jiang more than expected).

Fields of papers citing papers by Huiwen Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiwen Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiwen Jiang. The network helps show where Huiwen Jiang may publish in the future.

Co-authorship network of co-authors of Huiwen Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Huiwen Jiang. A scholar is included among the top collaborators of Huiwen Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiwen Jiang. Huiwen Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yingying, Jiachen Liu, Lijuan Zhou, et al.. (2025). Bone marrow blasts- and modified EASIX-guided risk stratification for coagulopathy and outcomes after CAR-T therapy in relapsed/refractory B-ALL. Thrombosis Research. 256. 109527–109527.
3.
Li, Yingying, et al.. (2025). Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications. Annals of Hematology. 104(7). 3537–3551. 1 indexed citations
4.
Li, Yingying, Zhong Wu, Huiwen Jiang, et al.. (2024). IL-1β Induce CAR-T-Associated Coagulopathy Via the Hsp90/Kallikrein/uPA Pathway. Blood. 144(Supplement 1). 1197–1197. 1 indexed citations
5.
Tang, Yuxiang, Hang Hu, Huiwen Jiang, et al.. (2024). Elevating the potential of CAR-T cell therapy in solid tumors: exploiting biomaterials-based delivery techniques. Frontiers in Bioengineering and Biotechnology. 11. 1320807–1320807. 7 indexed citations
6.
Li, Yingying, Zhong Wu, Huiwen Jiang, et al.. (2024). Gut Microbial Metabolite Butyrate Alleviates the Susceptibility to Septic DIC By Suppressing Caspase-11/ Gsdmd-Dependent Macrophage Pyroptosis. Blood. 144(Supplement 1). 3993–3993.
7.
Zhang, Yinqiang, Chenggong Li, Mengyi Du, et al.. (2023). Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood Cancer Journal. 13(1). 61–61. 52 indexed citations
8.
Jiang, Huiwen, Yujia Wang, Pu Ge, et al.. (2023). Application of Anderson model to analyze the influencing factors of lung function test behavior in middle-aged and elderly people in China. SHILAP Revista de lepidopterología. 2. 100138–100138. 3 indexed citations
9.
Li, Qiyu, Huiwen Jiang, Jingbo Zhang, et al.. (2022). Current Status and Influencing Factors of Eating Behavior in Residents at the Age of 18~60: A Cross-Sectional Study in China. Nutrients. 14(13). 2585–2585. 20 indexed citations
10.
Li, Chenggong, Yan Sun, Jing Wang, et al.. (2021). PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report. Frontiers in Immunology. 12. 599493–599493. 13 indexed citations
11.
12.
Tang, Lu, Jianghua Wu, Huiwen Jiang, et al.. (2020). Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia. Clinical Cancer Research. 26(7). 1763–1772. 88 indexed citations
14.
Jiang, Huiwen, et al.. (2020). Diagnostic values of shear wave elastography and strain elastography for breast lesions. Revista médica de Chile. 148(9). 1239–1245. 9 indexed citations
15.
Wang, Jing, Wei Shi, Bo Zhang, et al.. (2019). Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. Acta Biomaterialia. 90. 324–336. 24 indexed citations
16.
Tang, Lu, Yizhong Peng, Chenggong Li, et al.. (2019). Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis. Journal of Cancer. 10(3). 654–664. 14 indexed citations
17.
Li, Chenggong, Heng Mei, Yu Hu, et al.. (2019). A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial. Blood. 134(Supplement_1). 930–930. 67 indexed citations
18.
Jiang, Huiwen, Lin Liu, Tao Guo, et al.. (2019). Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy. Annals of Hematology. 98(7). 1721–1732. 91 indexed citations
19.
Tang, Lu, Huan Zhang, Chenggong Li, et al.. (2019). Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis. BMC Cancer. 19(1). 849–849. 10 indexed citations
20.
Jiang, Huiwen, Heng Mei, Jian Dong, & Yu Hu. (2017). Abnormal Coagulation Function in CD19-Targeted CAR-T Therapy. Blood. 130. 2607–2607. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026